The fact that your son is well means that his rash is unlikely to be due to anything serious. It may well clear up on its own over the next few days.

Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free survival in CSCC in the adjuvant setting, reducing the risk of ...

“Severe nausea and vomiting (hyperemesis gravidarum) are common because levels of pregnancy hormones such as hCG and estrogen ...

Company Announcement EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line settingIn the ...